3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
706
Carcinoma, Non-Small-Cell Lung
475
Prostatic Neoplasms
423
Neoplasms
383
Multiple Myeloma
263
Colorectal Neoplasms
261
Lung Neoplasms
247
Neoplasm Metastasis
231
Melanoma
217
Ovarian Neoplasms
191
Leukemia, Myeloid, Acute
191
Pancreatic Neoplasms
181
Squamous Cell Carcinoma of Head and Neck
162
Carcinoma, Renal Cell
146
Recurrence
143
Lymphoma
141
Glioblastoma
139
Lymphoma, Non-Hodgkin
134
Stomach Neoplasms
129
Triple Negative Breast Neoplasms
128
Carcinoma, Hepatocellular
123
Leukemia, Lymphocytic, Chronic, B-Cell
122
Brain Neoplasms
122
Head and Neck Neoplasms
117
Uterine Cervical Neoplasms
116
Urinary Bladder Neoplasms
114
Precursor Cell Lymphoblastic Leukemia-Lymphoma
114
Lymphoma, Large B-Cell, Diffuse
105
Sarcoma
103
Lymphoma, Follicular
100
Interventions
Mifepristone
1
Etanercept
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Interventional
×
Gulf War Illness
×
Clear all
NCT04254627
2025-02-19
E/M
Nova Southeastern University
Phase 1
Active not recruiting
20 enrolled